Written by gozerian Hear it First: Join our Mailing List Sign up to receive new product updates, exclusive discounts, news, and more!
Islam et al., "Vasopressin neurons in the paraventricular hypothalamus promote wakefulness via lateral hypothalamic orexin neurons," Curr
It represents the first and only oral formulation of a GLP-1 receptor agonist, offering an alternative to injectable semaglutide preparations
Health and Human Services, who himself is advocating peptides, stem cells, and other interventions for which data are lacking
Ensuring sufficient and quality sleep is essential for overall health
A new generation of oral tablets, multi-target agonists, and next-generation injectables is reshaping the competitive landscape at pace, with fresh regulatory approvals, pivotal Phase 3 data, and an expanding list of indications that stretches far beyond weight loss and type 2 diabetes